POM
POMDOCTOR LIMITED American Depositary Shares
NASDAQ: POM · HEALTHCARE · PHARMACEUTICAL RETAILERS
$0.38
+2.21% today
Updated 2026-04-30
Market cap
$50.01M
P/E ratio
—
P/S ratio
0.14x
EPS (TTM)
$-0.05
Dividend yield
—
52W range
$0 – $6
Volume
1.3M
POMDOCTOR LIMITED American Depositary Shares (POM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $34.00M | $68.00M | $127.00M | $131.00M | $44.00M | $59.00M | $686.00M | $592.00M | $497.00M | $854.00M | $939.00M | $8.45B | $7.48B | $8.64B | $85.00M | $-34.80M | $-15.68M | $-22.02M | $-45.80M | $-16.13M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $156.00M | $941.00M | $1.22B | $1.31B | $1.22B | $1.23B | $8.55B | $7.58B | $7.59B | $0.00 | $0.00 | $0.00 | $0.00 | $111891.00 | $37773.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free cash flow | $34.00M | $68.00M | $127.00M | $131.00M | $44.00M | $-97.00M | $-255.00M | $-624.00M | $-813.00M | $-369.00M | $-291.00M | $-108.00M | $-104.00M | $1.05B | $85.00M | $-34.80M | $-15.68M | $-22.02M | $-45.91M | $-16.17M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |